Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 13;69(Suppl 7):S521-S528.
doi: 10.1093/cid/ciz824.

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria

Affiliations
Review

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria

Patrice Nordmann et al. Clin Infect Dis. .

Abstract

Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow. Although carbapenemase-producing Enterobacteriaceae have received the most attention because resistance was first reported in these pathogens in the early 1990s, there is increased awareness of the impact of carbapenem-resistant nonfermenting gram-negative bacteria, such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. Moreover, evaluating the problem of carbapenem resistance requires the consideration of both carbapenemase-producing bacteria as well as bacteria with other carbapenem resistance mechanisms. Advances in rapid diagnostic tests to improve the detection of carbapenem resistance and the use of large, population-based datasets to capture a greater proportion of carbapenem-resistant organisms can help us gain a better understanding of this urgent threat and enable physicians to select the most appropriate antibiotics.

Keywords: Acinetobacter baumannii; Pseudomonas aeruginosa; carbapenem-resistant Enterobacteriaceae; carbapenemases; gram-negative bacteria.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Classification of carbapenemases/β-lactamases depending on their central catalytic domain. Adapted from [17]. Abbreviations: ACT, AmpC type β-lactamase; AmpC, ampicillin chromosomal cephalosporinase; CMY, cephamycin-hydrolyzing β-lactamase; CTX-M, cefotaxime-hydrolyzing β-lactamase–Munich; FOX, plasmid-mediated class C β-lactamase; GES, Guiana extended-spectrum β-lactamase; IMI, imipenem-hydrolyzing β-lactamase; IMP, imipenemase metallo-β-lactamase; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase; OXA, oxacillin carbapenemase/oxacillinase; SHV, sulfhydryl variant of the TEM enzyme; SME, Serratia marcescens enzyme; TEM, Temoneira class A extended-spectrum β-lactamase; VIM, Verona integron-encoded metallo-β-lactamase.
Figure 2.
Figure 2.
Number of infections caused by carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli based on the Premier Healthcare Database. Adapted from [3]. Abbreviation: CR, carbapenem resistant.
Figure 3.
Figure 3.
Distribution of carbapenem resistance mechanisms in Enterobacteriaceae species in the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) study. Adapted from [62]. Abbreviations: AmpC, ampicillin chromosomal cephalosporinase β-lactamase; CR, carbapenem resistant; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase; OXA, oxacillin carbapenemase/oxacillinase; VIM, Verona integron-encoded metallo-β-lactamase.
Figure 4.
Figure 4.
Algorithm to assess potential carbapenem resistance mechanisms in Enterobacteriaceae and nonfermenter species. Abbreviations: CPE, carbapenemase-producing Enterobacteriaceae; CPO, carbapenemase-producing organism; CR, carbapenem resistant; CRE, carbapenem-resistant Enterobacteriaceae; IMP, imipenemase metallo-β-lactamase; KPC, Klebsiella pneumoniae carbapenemase; L1, a class B metallo-β-lactamase; MBL, metallo-β-lactamase; NDM, New Delhi metallo-β-lactamase; OXA, oxacillin carbapenemase/oxacillinase; VIM, Verona integron-encoded metallo-β-lactamase.

References

    1. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics.2017. Available at: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET.... Accessed 1 February 2019.
    1. van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013; 75:115–20. - PMC - PubMed
    1. Cai B, Echols R, Magee G, et al. . Prevalence of carbapenem-resistant gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis 2017; 4:ofx176. - PMC - PubMed
    1. Cai B, Echols R, Morgan G, et al. . Carbapenem-resistant gram-negative pathogens among hospitalized patients in the United States between 2010 and 2015. Poster presented at: IDWeek 2016, New Orleans, LA,25–30 October 2016; Poster 362.
    1. Kim T, Lee EJ, Park SY, et al. . Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: a retrospective multicenter study in Korea. Medicine (Baltimore) 2018; 97:e12984. - PMC - PubMed

Publication types

MeSH terms